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Abstract: The multiplexed biosensing of target molecules with high specificity and accuracy is of 
fundamental importance in both biological research and medical diagnostics. In this paper we 
extend the working range of our recent nanopore-DNA carrier based method by introducing a 
two-step assay using specific DNA aptamers. A signal translation step allows for binding of the 
target in physiological conditions before the nanopore measurements. Using protein encoded 
DNA carriers, we demonstrate the simultaneous detection of 3 targets spanning several orders of 
magnitude in molecular weight. Our single-molecule method may be integrated into nanopore 
sensing devices for future applied research and point of care applications. 
 
 
1. Introduction 
Growth in the field of biosensors has been phenomenal.[1] Single molecule techniques, which 
allow analyte molecules to be examined individually,[2] have been showing great potential to meet 
the stringent requirements of both fundamental research and future point of care devices. Among 
these novel sensing techniques, nanopore based biosensors have emerged as an exciting possibility 
  
2 
 
and have been applied to a variety of biological systems such as viral genomes,[3] disease related 
DNA or RNA,[4-6] antibodies,[7] transcription factors[8] and other proteins.[9] Instead of modifying 
the nanopore surface, another approach using DNA molecules as information carriers has shown 
potential as a highly adaptable sensing platform. Both small carriers of tens of base pairs[5, 10] and 
long molecules of few thousand base pairs[11-12] have been shown with potential towards 
multiplexed sensing. The key idea is to program a long double-stranded DNA (carrier) with 
specific binding sites and a barcode for identification.[13] Specific features in the ionic current 
signal confirm the presence of the target when the DNA carrier with the corresponding binding 
site passes through the nanopore. In previous studies, basic sensing functions including target 
identification, concentration quantification in the nanomolar range [14] and real time kinetics 
screening[15] have been demonstrated, and multiplexed detection of high affinity antibodies was 
achieved.[13] 
Until now, the nanopore based DNA carrier approach has relied on measurements in high salt 
concentrations of up to 4 M LiCl. The high salt conditions enhance the signal to noise ratio[16] and 
slow down the target translocation.[17] However, the specific binding of many relevant biological 
targets is destabilized in these conditions. Although measurements in lower concentration buffers 
can be achieved,[12] the sensing resolution and reading of detailed information encoded in the DNA 
carrier is severely limited. In this work, we demonstrate a two-step assay combining aptamer-based 
DNA circuits with our nanopore DNA carrier method to detect targets beyond tight binding 
proteins and antibodies. In Step 1, an aptamer-based DNA circuit is used to translate information 
about the target into an output DNA strand. In Step 2, the output DNA strand is read by nanopore 
sensing via a sequence specific DNA strand displacement reaction on the DNA carrier. Separating 
the process into two steps allows the bio-interactions to be carried out in adjustable physiological 
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conditions and the signal translation enables the detection of small targets which cannot produce 
a distinguishable secondary current drop by attaching to the DNA carrier directly. In the 
subsequent sensing step, we are able to use buffers with high salt concentration to maximize the 
readout resolution. 
2. Results and Discussions 
2.1. Design of the two-step sensing scheme 
As a first demonstration of our two-step sensing scheme we chose adenosine triphosphate (ATP) 
as the target. Aptamer tuned DNA strand displacement[18] was adapted to translate the ATP signal 
into an output strand.[19-21] In Figure 1a (Step 1), the ATP binding aptamer and toehold binding 
domain (ABA) are shown in blue and orange, respectively. After incubation at 37℃ for two hours, 
the ABA strand forms a G-quadruplex upon binding to ATP molecules in the sample. This change 
in conformation inhibits the hybridization of ABA to the substrate, resulting in an open toehold A 
(orange) on the substrate. The input strand containing the complementary sequence of toehold A 
will then initiate the strand displacement reaction and thus release the output strand. In the case of 
no ATP in the sample, the input strand will not be able to release the output strand due to the closed 
toehold A.  
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Figure 1. Schematic presentation of the two-step assay design. (a) Aptamer-based signal 
translation using a specifically designed DNA circuit (Step 1 of the sensing scheme). (b) 
Nanopore-based readout of the output strand. Example events are shown after incubation with 
monovalent streptavidin (blue-grey rectangles) for ‘occupied’ or ‘empty’ DNA carriers where the 
biotinylated strand is removed by the output strand. The blue rectangle represents the only active 
subunit of the monovalent streptavidin molecule.  
In the second step (Figure 1b), DNA carriers functionalized with a specific toehold B (red) were 
used to examine the presence of the output strand and hence for ATP detection. Following our 
previous protocols,[11] the DNA carriers were constructed using a 7228 bases long linear single-
stranded ‘scaffold’ hybridized to 190 short (38 bases) synthetic DNA oligonucleotides. Only one 
sensing site was placed at the centre of the DNA carrier for establishing the sensing protocol. At 
the sensing site, a specific toehold probe is designed presenting an accessible overhang. A biotin 
labelled (blue spot) probe Ab is initially hybridized to part of the toehold probe and the toehold B 
is left free. Containing the complementary sequence to toehold B, the output strand can efficiently 
initiate the displacement reaction and eventually remove the biotin labelled Ab from the sensing 
site. Therefore, the monovalent streptavidin[22] added cannot bind and produce the secondary 
current drop signal in the ionic current signal. As shown in the example translocation events 
(Figure 1b), the ‘empty’ event without a secondary current drop corresponds to a DNA carrier 
without a biotin label and hence signals the presence of ATP. In the case of absence of ATP output 
strand, the translocation event appears ‘occupied’. The fraction of empty events is the indicator for 
the existence of the output strand in the sample. It is important to notify that with our DNA carrier 
approach no modification of nanopores is necessary as the information is stored in the analytes. 
2.2. Characterization of the two-step sensing scheme 
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We first examined how efficiently empty and occupied events can be differentiated. DNA 
carriers with biotin labelled probe Ab or the output strand added directly in the carrier synthesis 
were measured with the same nanopore for comparison. Figure 2a shows the peak current drop 
amplitude distributions of the two carriers. Fitted by a Gaussian function, the main peaks from the 
empty and occupied samples are −0.15 ± 0.01 nA and −0.18 ± 0.01 nA (mean ± s.d., the same 
format in other parts), demonstrating two well resolved populations. As the smaller peak represents 
the current drop level of bare dsDNA, the ratio of ~1.2 between the two peaks is used as a threshold 
factor to define an occupied event in our analysis. A smaller peak is also shown in the distribution 
of the occupied carriers (Figure 2a, right), which is most likely caused by imperfect DNA carriers 
missing the biotin label. A constant background of around 10% is present in our previous work.[14]  
 
Figure 2. Proof-of-concept of the two-step assay with the ATP-aptamer system. (a) Peak current 
drop distributions of occupied and empty DNA carrier translocation events. The histograms were 
fitted by a Gaussian function. The event numbers for occupied and empty samples are 669 and 
365, respectively. (b) ATP detection using the two-step assay. The Blank control (black) was 
measured with labelled DNA carriers before any reactions. The ‘Target-’ (grey) and ‘Output+’ 
(white) controls were measured by incubating the DNA carriers with ATP free DNA circuits or 
excess amount of output strands. The CTP experimental group (purple) was to demonstrate the 
specificity of the DNA circuit. The data contains 4143 events measured with 17 nanopores. 
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Two control conditions were introduced to benchmark the readout fraction range of the occupied 
fraction readout (Figure 2b): output strands with 20 times molar concentration of the DNA carrier 
were incubated with the carrier to achieve the ‘output+’ result. For the ‘target-’ control we 
incubated the carriers with ATP free DNA circuit. Occupied fractions of these two controls read 
at 0.08 ± 0.01 and 0.64 ± 0.06 respectively. The lower limit is likely caused by the presence of 
DNA folds or knots[23] in the carrier that produce similar signals as the streptavidin label. The 
upper limit levels off at 0.64, lower than the expected occupied fraction of 1, which we attribute 
to two reasons. First, a small fraction of imperfect carriers without biotin labels is unable to 
contribute to the occupied fraction, as shown in Figure 2a. Second, a small amount of free or 
‘leaked’ output strands may initiate strand displacement even in the absence of ATP. The occupied 
fraction of blank DNA carriers sample without any incubation is measured as another control. The 
occupied fraction of 0.86 ± 0.03 indicates that the initial reduction from 1 to ~0.86 is probably due 
to the imperfect DNA carriers while the rest from ~0.86 to ~0.64 is probably from the ‘leaked’ 
output. Better purification of the DNA circuits components and optimized designs may improve 
the readout fraction range.[24-25] 
The occupied fraction with the ATP positive sample (Figure 2b, red) is 0.25 ± 0.04, showing a 
drop by 61% in occupied fraction compared to the ‘target-’ control. Reference electrophoresis 
assay is shown in Figure S4. CTP, GTP, TTP and UTP with the same concentration were measured 
to examine the ATP specificity of the designed DNA circuit (Figure S5). For CTP, the occupied 
fraction (Figure 2b, purple) we measured is 0.57 ± 0.09, only 11% lower than the ‘target-’ control. 
Our results demonstrate a successful detection of ATP with high specificity. It has to be noted that 
the ‘ATP’ occupied fraction (0.25) is higher than the lower limit (0.08), as the displacement 
reaction was probably not fully complete. Although higher concentration ratios between DNA 
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circuits and carriers could help to reach a more complete reaction, the background signal increases 
in parallel.[15]  We use the concentration ratio of 10 in all the measurements to balance between 
high response with low background.  
2.3. Protein based barcoding  
In order to read multiple output strands simultaneously, we designed DNA carriers with a 
‘coding’ region in the first half and a ‘sensing’ site in the middle of the second half (Figure 3b). 
The ‘coding region’ was constructed by having a protein attached as an individual sensing bit. 
Streptavidin and digoxigenin antibodies (anti-dig) were used to realize the digital readout given 
their tolerance to high salt conditions.[14] Precisely located binding of the protein bits was achieved 
by modifying the DNA oligo in the desired location with a biotin or two digoxigenin labels. Due 
to the different size of the two protein molecules, secondary current drops of two levels were 
observed in the translocation events (Figure 3b): small secondary peaks from streptavidin (~53 
kDa) are read as ‘0’ and the anti-dig (150 kDa), corresponding to the larger peaks, indicate ‘1’. 
The distribution of current drop levels of the ‘0’ and ‘1’ bits shows two well separated populations 
(Figure S1). Figure 3b shows the library of the 3 bits encoded DNA carriers. To verify the barcode 
reading accuracy, the library of 8 encoded carriers were mixed with the same molar concentration 
and measured in the same nanopore. Roughly equal quantities are observed for each barcode within 
pipetting errors (Figure S2). The use of single proteins yields adequate digital signals while 
simplifies the design of the coding region compared to an earlier strategy.[13]  
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Figure 3. Digitally encoded DNA carrier designs using proteins. (a) Schematic presentation of the 
multiplexed DNA carrier-nanopore sensing platform. Selectivity is introduced by assigning the 
carrier with a specific barcode for each target system. (b) Designed DNA carriers consist of a 
coding region and a sensing region. Attached streptavidin (bit=0, yellow spot) and anti-dig (bit=1, 
green spot) produce secondary current drops of two amplitude levels. The coding region can be 
found either in the first or second half of the event depending on the orientation of the DNA carrier 
when entering the nanopore. 
2.4. Multiplexed sensing capability of the two-step sensing scheme  
Two other targets, thrombin and lysozyme, were added to demonstrate the multiplexed 
capability of the two-step assay (Figure 3a). With our protein coding, we assigned the barcodes 
010, 011 and 100 to ATP, thrombin and lysozyme system respectively (Figure 4b). The barcode 
001 is designed with an anti-dig bound to the sensing site as a referential marker. For the other 3 
DNA carriers, the sensing site was designed in the same fashion as the strand displacement sensing 
site used for ATP. Each encoded DNA carrier has a toehold region in the overhang probe that 
reacts only to the output strand from its specific target. The DNA circuits for the three targets were 
designed to follow the same pattern and the experimental protocols were exactly the same as for 
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ATP detection. All three DNA circuits were mixed together in the experimental groups. Results of 
our multiplexed measurements are shown in Figure 4c.   
The drop in occupied fraction (drop%) is used to indicate signal changes due to the target 
presence. Since the ‘001’ carrier was fully labelled and measured in the same nanopore, its 
occupied fraction was set as 1, yielding an internal reference in these measurements. The 
percentage drop of the occupied fraction from the reference in each measurement can then be used 
to determine whether a specific target exists in the sample or not. As shown in Figure 4c, ‘output+’ 
and ‘target-’ controls were carried out by incubating the mixed DNA carriers with three output 
strands or target free DNA circuits. The three targets were added individually or together in four 
experimental groups. The drop% threshold of 30% is used to determine a positive detection. We 
marked values above the threshold in bold. Expected positive detections are shaded in 
corresponding colours for the three systems. Our results show a perfect match between the 
expected and detected targets. Our multiplexed assays successfully detected all 3 targets 
individually and simultaneously. Each control and experimental group was measured with several 
nanopores (p1-p17). 
 
  
10 
 
 
Figure 4. Multiplexed two step sensing using 3 aptamer-based systems. (a) Three targets with 
molecular weights between a few 100 Da (ATP) and a few 10 kDa (thrombin and lysozyme). (b) 
The complete designs of three specific DNA carrier structures with different barcodes. ‘010’, ‘011’ 
and ‘100’ are assigned to ATP, thrombin and lysozyme respectively. (c) DNA carrier-nanopore 
results of the multiplexed samples. The percentage drop of the occupied fraction from the reference 
in each measurement is used here to indicate the signal changes due to the target presence. The 
two controls were measured by incubating DNA carriers with the 3 output strands (Output+) or 
target free DNA circuits (Target-). Drop% above 30% is marked in bold and the expected positive 
detection is shaded in red, blue and green for ATP, Thrombin and Lysozyme accordingly. 3365 
assigned events from 17 different nanopores were considered in this table. (d) Fluorescent-
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quencher probe pairs used in the reference bulk assay. The 3 colours correspond to the three target 
systems. (e) Fluorescent spectrum when all 3 targets present in the sample. 
In order to compare the performance of the nanopore-DNA carrier readout and traditional bulk 
measurements, we carried out a standard fluorescent-based assay. A pair of fluorescent and 
quencher probes was adapted from the overhang probes on the carrier sensing sites. As shown in 
Figure 4d, the fluorophore is initially quenched in the DNA duplex. Upon the presence of the 
output strand AO, TO or LO, the same displacement as on the DNA carrier sensing site removes 
the quencher strand QA, QT or QL. However, the readout signal is the recovered fluorescent 
intensity instead. Multiplexed sensing was achieved by using 3 different fluorophores for the 3 
targets: FAM for ATP, TYE-563 for thrombin and TEX-615 for lysozyme. Excited separately at 
the corresponding wavelengths (495 nm for FAM, 549 nm for TYE-563 and 596 nm for TEX-
615), the fluorescent spectra of a sample containing all 3 targets are shown in Figure 4e. 
Fluorescent signals were observed at the respective maximum emission wavelengths of the three 
dyes (520 nm, 563 nm and 615 nm accordingly), which indicated the presence of all 3 targets in 
the sample. Additional fluorescent results of the other experimental groups are shown in Figure 
S6. To investigate the effect of high salt concentration on the target recognition in step 1, 
fluorescence measurements in buffers with and without 4M LiCl were compared (Figure S7) and 
results show that high salt concentration disrupts the binding for all 3 targets to their aptamer 
sequences. Although fluorophores with well separated excitation and emission wavelengths were 
used, signals show significant overlap in the fluorescence-based assay. For example in Figure 4e, 
the signal of TEX-615 is observed within the emission of TYE-563, which is due to the higher 
fluorescence quantum yield of TEX-615 compared to TYE-563. Spectral overlap and varied 
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fluorescence quantum yields can cause difficulties in understanding the multiplexed fluorescence 
data and set strict limits to the number of simultaneous targets.[26-28] 
3. Conclusion 
In summary, we have presented a two-step assay towards multiplexed and single molecule 
sensing in adjustable physiological conditions. In Step 1, the target signal is translated into an 
output DNA strand using an aptamer-based DNA circuit, while in Step 2, the output strand is read 
by a strand displacement designed on the DNA carrier. The separate Step 1 provides the biological 
reaction with optimal physiological conditions. The translation of the signal into an output DNA 
strand allows for the detection of molecules ranging from a few hundred Daltons (ATP) up to tens 
of kilo Daltons using nanopore sensing in high ionic strength buffer. We also demonstrate the 
multiplexing capability of the developed sensing scheme, 3 bits protein encoded DNA carriers 
were used to simultaneously detect 3 target molecules that vary in size and affinity. The total assay 
time required is ~1.5 hours for step 1 and ~4 hours in step 2, with an active handling time of around 
1 hour. Multichannel nanopore recordings can be applied to reduce the time required in step 2. Our 
two-step assay has built a bridge between the nanopore-based single-molecule method and DNA-
based circuitry[29-30] designs. Apart from the aptamer-based conformation changes used in this 
work, direct binding of antibodies and other proteins can also facilitate successful signal translation 
into output strands.[31-33] Compared to the traditional fluorescence assays, our method avoids 
fluorophores conjugation and spectra overlap. Furthermore, sensing performance can be further 
enhanced for example by signal amplification via enzyme free hybridization chain reactions,[34-35] 
in Step 1. Throughput can be further improved in both the DNA carrier design and nanopore 
resolution. Under current experimental conditions, the minimum spacing between two resolved 
secondary current drops is around 200 bp (Figure S3). Given the 7.2 kbp length of the DNA carrier, 
more than 10 bits can be fit in the coding region, providing a carrier library of 210 = 1024. In case 
  
13 
 
more targets are necessary, thin membrane nanopore devices made from SiN[36-37] and 2-
dimensional materials[38-40] should increase the number of readable bits on the carrier. 
 
4. Experimental Section  
DNA carrier synthesis   
    DNA carriers were constructed using a 7228 bases long linear single-stranded ‘scaffold’ 
hybridized to 190 short synthetic DNA oligonucleotides. The length of each DNA oligo is 38 bases. 
The hybridization was carried out by heating up the mixture of the scaffold (20 nM) and oligos 
(60 nM each) to 70℃ and then cooled down linearly to 25℃ over 1 hour. A concentration of 120 
nM was used for all modified oligos in the mixture. 14 mM MgCl2 buffered with TE was used in 
this hybridization. The DNA carriers were then purified using Amicon Ultra 100 kDa cutoff 
centrifugal filters. Three centrifuge rounds of 3000 g at 4℃ were carried out, each lasting for 10 
minutes. The modified oligo sequences for both sensing and coding region are shown in Table S1 
and Table S2. Full sequences of the 190 short DNA oligos can be found in our previous 
papers.[11,13] 
Nanopore fabrication and experimental setup 
    Glass nanopores used in this work were fabricated with a laser-assisted puller (P-2000, Sutter 
Instrument, USA). Details of the nanopore geometry including SEM images and a 3D model with 
two taper angles are as described previously.[11,13] The current drop amplitude contributed by the 
bare double-stranded DNA (dsDNA level) was used to indicate the nanopore size. The dsDNA 
level is averaged at -0.129 ± 0.019 nA over the 43 nanopores used in this paper. Ionic current 
measurements were carried out using a standard patch clamp amplifier (Axopatch 200B, Molecular 
Devices, USA). 600 mV bias voltage was applied in all the measurements at the sampling 
frequency of 250 kHz. The data was filtered at 49.9 kHz with an external 8-pole Bessel filter.  
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Experimental protocol of the two-step assay 
    Step1: The M13mp18 DNA scaffold was purchased from New England BioLabs and all DNA 
oligos were ordered from Integrated DNA Technologies. 100 mM NaCl, 10 mM KCl and 10 mM 
MgCl2 buffered with 10 mM Tris-HCl, pH 8 was used in all incubations, where K
+ was included 
to help the formation of G-quadruplex structures. The substrate was hybridized by heating up the 
two strands to 88 ℃ for 5 minutes and then cooling down linearly to room temperature over 30 
minutes. The ABA hybridization and input strand displacement were carried out at room 
temperature for 1 hour. The concentrations of the DNA circuit (ABA-substrate) and ATP (Thermo 
Fisher Scientific) used in step 1 are 100 nM and 300 µM, while 120 nM input strands were added 
to ensure maximum release of the output strands. For other target systems, 60 nM Thrombin 
(Haematologic Technologies) and 29 µM lysozyme (Sigma-Aldrich) were used in the incubations. 
Quantitative concentration measurements were not carried out in this work, however the feasibility 
of measuring concentrations has been demonstrated in our previous work. [14,15] Gel electrophoresis 
was used as reference assay to validate the structural changes in the DNA circuit (Figure S4).  
    Step 2: DNA circuits of 3 nM were incubated with 0.3 nM DNA carriers for 2 hours at room 
temperature to reach the ‘complete’ state of the displacement reaction.[14] Given the sample volume 
of ~10 µL required in our device,[41] the total amount of DNA carrier is only 3 femtomolar. As for 
the multiplexed measurements, equal amounts of 4 encoded DNA carries were mixed to make a 
total concentration of 0.3 nM. The incubation buffer was the same as in Step 1, while 4 M LiCl 
was only added for the nanopore measurements. 4.8 nM anti-dig were added 10 min before the 
measurements together with 2.4 nM streptavidin to amplify the secondary signals in both coding 
region and sensing region. 
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The multiplexed biosensing with high specificity and accuracy is of fundamental importance in 
biological research and point of care diagnostics. Combining aptamer based DNA circuits and 
protein encoded DNA carriers, we present a two-step assay that expands the working range 
beyond just tight binding model systems. The results demonstrate a simultaneous detection of 3 
targets varies in molecular weight and affinity. 
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